Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

ALIVUS ☆ BSE also on NSE

ALIVUS LIFE SCIENCES LIMITED · code 543322 · INE03Q201024 · Pharma & Healthcare · series A · Daily price history

1,449.85 +4.85 (+0.34%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
77

ISA Signal Score: Strong setup

Buy candidate: research it further. Based on prices to 2026-11-19. Confidence 100%.

Trend100
Momentum57
52-week range89
Volume85
Risk72
Fundamentals62

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • RSI 58: healthy strength
  • Within 5% of its 52-week high

Working against it

  • MACD is negative and weakening

Measured reference levels (not forecasts): 20-day low 1,247.30, 52-week high 1,520.90, typical daily move 65.94, two typical moves below price 1,317.98.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityStrongROE 21.1%, ROCE 27.5%, almost no debt
GrowthFastSales 20.8%, profit 19.2% a year over 5 years
ValuationFairP/E 37.7 vs sector median 46.4, 7.6x book
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 61.7 points
RiskMediumSwings 29% a year, fell up to 14% from a peak, beta 0.50

Smart Investor Tips: ALIVUS

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • Confirmed uptrend: trading above both rising 50-day (Rs 1,384.14) and 200-day (Rs 1,160.71) averages.
  • Strong earnings compounding: net profit grew at 19.2% CAGR over 5 years.
  • High capital efficiency: ROE of 21.1% indicates strong returns on shareholder equity.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Momentum Prediction & Optimal Entry PriceBUY / POSITIVE IN ZONE (Score 98/100)

Strong technical, volume & cash-flow setup. Best support area: Rs 1,363.38 – Rs 1,435.35 (Ideal entry ~Rs 1,399.37). Stagger 50% near Rs 1,435.35 and 50% near Rs 1,363.38. Risk level / review below Rs 1,073.14; Swing Target Rs 1,986.58 (R:R 1.8x).

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 1,363.38 – Rs 1,435.35
Ideal ~Rs 1,399.37
Rs 1,435.35 Rs 1,363.38 Rs 1,073.14
ATR 4.6%
Rs 1,986.58 Rs 2,378.06 1 : 1.8
RSI 61 · Vol 4.47x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +37.3% · high 1,553.50 · low 996.05 · max drawdown -13.6%

Live Candlestick & TradingView Chart (ALIVUS)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY24 standalone, price 19 Nov

P/E37.7sector median 46.4
P/B7.62xprice / book value
EPSRs 38.43grew 16.2% a year
Dividend yield-from saved dividend events
Debt to equity0.00xmore cash than debt
Sales growth20.8%a year over 5 years
Profit growth19.2%a year over 5 years
Operating margin29.5%net margin 20.6%

From the official NSE results filings, standalone. P/E uses the last full year's EPS, PEG 1.97, EV/EBITDA 25.9. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY24 Standalone Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Strong Balance Sheet & Cash Flow · Score 87/100
Total Debt / Loans Rs 0 Cr Reduced Rs 0 Cr YoY
Cash & Bank Balances Rs 302 Cr Liquid cash & equivalents
Net Debt (Loans − Cash) Net Cash Rs 302 Cr Debt-free on net basis
Debt to Equity & Interest Cover 0.00x D/E Interest cover: 408.3x EBIT
Operating Cash Flow (OCF) Rs 414 Cr OCF/PAT conversion: 88%
Free Cash Flow (FCF) Rs 285 Cr After Capex of Rs 129 Cr
  • Net Cash / Debt-Free balance sheet (Cash Rs 302 Cr exceeds Total Loans Rs 0 Cr).
  • Strong loan interest coverage (408.3x EBIT/Interest).
  • Positive Free Cash Flow (Rs 285 Cr after Capex) available for debt reduction & dividends.

About ALIVUS LIFE SCIENCES

Healthcare

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed06 Aug 2021BSE not available · NSE 06 Aug 2021
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness3 of 8Missing: description, share count, book value, ROE, ROCE

Checked: BSE 19 Nov 2026. Yahoo Finance did not answer (HTTP 0).

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 74.85% -0.02 pp, public 25.15%, as on 30 Sep 2026. Holder names and history

Day range1,440.10 to 1,470.20Open 1,440.10
52-week high1,553.50 -6.7% from high (09 Nov 2026)
52-week low830.00 +74.7% from low (22 Jan 2026)
Volume8,908 0.2x the 20-day average
RSI (14)58 neutral
Volatility (30d)35.8%annualised
830.00
1,553.50

Returns

1W+0.5%
1M+13.9%
3M+5.8%
6M+37.3%
1Y+59.7%
YTD+58.1%
3Y a year+32.3%
5Y a year+18.3%

Against the NIFTY 50

PeriodALIVUSNIFTY 50Difference
1M+13.9%+11.5% +2.4 pts
3M+5.8%+5.3% +0.5 pts
6M+37.3%+7.9% +29.5 pts
1Y+59.7%-2.1% +61.7 pts

Risk over the past year

Volatility29%medium
Deepest fall-13.6%from a peak
Beta0.50moves less than the index
Best day+10.3%04 Aug 2026
Worst day-4.2%02 Feb 2026
Up days48%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 7 / 9 · Fortress Balance Sheet
3-Step DuPont ROE Identity: High Pricing Power & Margin Leader
Net Margin: 20.6% × Asset Turnover: 0.80x × Equity Multiplier: 1.22x = ROE 21.1%
✓ Positive Net Profit (PAT > 0) Rs 471 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 414 Cr
✓ High Cash Conversion (OCF >= 85% of PAT) 88% conversion
⚠ Improving Return on Assets (ROA YoY) 16.5% vs 17.3%
✓ Conservative / Decreasing Debt-to-Equity 0.00x (prev 0.00x)
✓ Healthy Balance Sheet Asset Coverage 6.50x
✓ Institutional Return on Equity (ROE >= 14%) 21.1%
⚠ Stable / Expanding Profit Margin YoY 20.6% vs 21.6%
✓ Asset Turnover Efficiency (Sales / Assets) 0.80x

Quarterly Results (Last 5 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Sales / Revenue 573537589507642
Sales QoQ % --6.3%+9.7%-13.9%+26.6%
Operating Profit 173141159134190
Operating Margin (OPM %) 30.1%26.4%27.1%26.5%29.7%
Net Profit (PAT) 11997.911195.3137
Profit QoQ % --17.5%+13.8%-14.5%+43.7%
Profit YoY % ----+15.3%
Net Margin % 20.7%18.3%18.9%18.8%21.3%

Sales and profit Rs crore, standalone

Sales growth+20.8%a year, 5Y
Profit growth+19.2%a year, 5Y
EPS growth+16.2%a year, 5Y
Avg ROE21.5%2 years

Profit and loss

Rs croreFY19*FY20*FY21*FY23FY24
Sales8861,5371,8852,1612,283
Sales growth-+73.5%+22.6%+14.7%+5.6%
Operating profit248472591642674
Operating margin28.0%30.7%31.4%29.7%29.5%
Other income012.01.0029.012.0
Interest1.0034.088.00.551.55
Depreciation19.029.033.042.153.5
Profit before tax228421471629631
Tax rate14.0%26.0%25.0%25.7%25.4%
Net profit196313352467471
Profit growth-+59.7%+12.5%+32.7%+0.8%
Net margin22.1%20.4%18.7%21.6%20.6%
EPS (Rs)18.1429.0432.6138.1138.43

Balance sheet

Rs croreFY19*FY20*FY21*FY23FY24
Equity (net worth)---2,1382,332
Borrowings---00
Cash---309302
Total assets---2,7022,850
Debt to equity---0.00x0.00x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY19*FY20*FY21*FY23FY24
Operating Cash Flow (OCF)---313414
Capital Expenditure (Capex)---170129
Free Cash Flow (FCF = OCF - Capex)---143285
OCF / Net Profit Conversion---0.67x0.88x
Total Borrowings / Loans---00
Cash & Bank Balances---309302
Trade Receivables (Cr)---807765
Receivable Days---136.25x122.36x
Inventories (Cr)---604667
Inventory Days---102.04x106.56x

Returns on capital

Rs croreFY19*FY20*FY21*FY23FY24
ROE---21.8%21.1%
ROCE---28.6%27.5%
Interest cover229.00x13.38x6.35x1,143.93x408.28x

Read from the official annual results filed with NSE (XBRL), standalone figures; years marked * are on the other basis because only that file was readable. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
WOCKPHARMAWOCKHARDT LTD. 2,186.60 +7.9% - 33,674 166.7 6.8 4.3% 6.4%
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,449.85 +0.3% - 17,768 37.7 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LABORATORIES LTD. 2,085.40 -0.0% - 15,839 34.6 6.8 19.7% 27.0%
ASTRAZENASTRAZENECA PHARMA INDIA LTD. 6,120.45 +1.9% - 15,301 94.7 21.5 22.7% 12.5%
AARTIPHARMAarti Pharmalabs Limited 1,024.80 +1.3% - 9,287 42.8 5.3 12.3% 11.7%
BLUEJETBlue Jet Healthcare Limited 516.80 -0.2% - 8,964 54.7 10.6 19.4% 23.0%
CIPLACIPLA LTD. 1,416.00 -0.3% - - 29.5 - - 13.7%
ALKEMAlkem Laboratories Limited 5,145.00 -1.1% - - 26.7 - 17.0% 16.0%
DIVISLABDIVIS LABORATORIES LTD. 11,178.00 +1.0% - - 115.6 - 15.3% 24.3%
RUBICONRUBICON RESEARCH LIMITED 1,726.00 +3.9% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LT 8,744.80 -0.8% - - 64.8 - 21.1% 7.9%
RAINBOWRainbow Children's Medicare Li 1,241.45 -1.3% - - - - - -
Sector median- 46.47.216.2%

The 12 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is above the 50-day (short-term uptrend) Price is above its 200-day average (long-term uptrend) RSI 58: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper quarter of its 1-year range and is lower than it was on 3% of days in the past year.

Support (prices below today's)

50-day average1,384.14-4.5%
20-day low1,209.00-16.6%
60-day low1,209.00-16.6%
200-day average1,160.71-19.9%
52-week low830.00-42.8%

Resistance (prices above today's)

20-day high1,553.50+7.1%
60-day high1,553.50+7.1%
52-week high1,553.50+7.1%

Zones buyers often watch

Lower quarter of the 1-year range 830.00 to 1,010.88 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 1,242.80 to 1,398.15 A common area for dips inside an uptrend.
Around the 200-day average 1,125.89 to 1,195.53 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -13.6%. Currently -4.7% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average1,418.94 Price is 2.2% above
50-day average1,384.14 Price is 4.7% above
200-day average1,160.71 Price is 24.9% above
RSI (14)58Neutral
MACD (12, 26, 9)26.66Below its signal line (momentum fading)
Volatility (30d)35.8%Medium yearly swings

Support and resistance

R21,483.48
R11,466.67
Pivot1,453.38
S11,436.57
S21,423.28

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 1,440.10 1,470.20 1,440.10 1,449.85 +0.34% 8,908
2026-11-18 1,464.70 1,495.50 1,439.75 1,445.00 -0.18% 8,312
2026-11-17 1,449.15 1,470.25 1,436.00 1,447.60 -0.06% 8,619
2026-11-16 1,460.60 1,486.75 1,441.90 1,448.50 -0.75% 8,018
2026-11-13 1,449.95 1,500.00 1,444.00 1,459.40 +1.12% 27,050
2026-11-12 1,463.00 1,484.90 1,438.05 1,443.30 -0.69% 20,696
2026-11-11 1,494.10 1,517.00 1,444.30 1,453.40 -1.49% 36,655
2026-11-09 1,534.95 1,553.50 1,466.00 1,475.40 -5.34% 30,473
2026-11-06 1,495.15 1,521.75 1,402.10 1,480.55 -1.12% 66,972
2026-11-05 1,529.00 1,532.95 1,485.00 1,497.25 -1.56% 16,781
2026-11-04 1,504.30 1,526.80 1,465.00 1,520.90 +2.75% 42,385
2026-11-03 1,450.00 1,500.30 1,443.00 1,480.20 +2.01% 88,527
2026-11-02 1,434.35 1,504.00 1,433.45 1,451.00 +3.07% 443,548
2026-10-30 1,437.20 1,497.00 1,385.50 1,407.80 +0.72% 324,226
2026-10-29 1,388.90 1,435.55 1,383.70 1,397.75 -0.20% 15,487
2026-10-28 1,343.15 1,407.05 1,332.65 1,400.50 +4.25% 16,204
2026-10-27 1,263.35 1,347.00 1,263.35 1,343.45 +6.44% 6,117
2026-10-26 1,231.80 1,275.20 1,230.55 1,262.20 +1.19% 2,553
2026-10-23 1,267.50 1,267.50 1,209.00 1,247.30 -1.59% 3,160
2026-10-22 1,227.90 1,274.40 1,227.90 1,267.50 +0.95% 1,386
2026-10-21 1,264.00 1,270.00 1,222.05 1,255.55 -1.36% 8,851
2026-10-19 1,309.15 1,334.35 1,258.00 1,272.90 -2.77% 4,897
2026-10-16 1,328.55 1,336.50 1,305.25 1,309.15 -2.53% 2,362
2026-10-15 1,341.50 1,353.95 1,328.80 1,343.15 -0.07% 825
2026-10-14 1,335.60 1,356.00 1,328.50 1,344.15 -0.10% 3,157
2026-10-13 1,340.40 1,348.40 1,309.40 1,345.45 +0.07% 2,408
2026-10-12 1,328.00 1,348.30 1,316.85 1,344.50 +1.35% 3,168
2026-10-09 1,324.80 1,341.00 1,298.70 1,326.60 -0.83% 4,881
2026-10-08 1,367.60 1,371.20 1,322.35 1,337.75 -2.38% 5,465
2026-10-07 1,390.00 1,390.00 1,361.75 1,370.30 -0.95% 1,817
2026-10-06 1,371.05 1,390.65 1,354.10 1,383.40 +0.84% 24,274
2026-10-05 1,394.50 1,396.10 1,349.90 1,371.90 -0.04% 2,871
2026-10-01 1,363.00 1,379.10 1,323.25 1,372.40 -0.49% 3,150
2026-09-30 1,364.40 1,390.00 1,364.40 1,379.10 +1.41% 5,284
2026-09-29 1,332.30 1,365.90 1,329.25 1,359.90 +1.12% 6,129
2026-09-28 1,362.90 1,374.70 1,337.45 1,344.80 -1.49% 3,943
2026-09-25 1,366.60 1,375.00 1,354.95 1,365.20 -0.21% 2,033
2026-09-24 1,383.00 1,395.30 1,357.45 1,368.05 -1.10% 4,587
2026-09-23 1,381.90 1,420.00 1,373.00 1,383.25 +0.60% 5,467
2026-09-22 1,399.10 1,420.00 1,367.10 1,375.05 -1.83% 6,235
2026-09-21 1,437.05 1,445.40 1,393.50 1,400.65 -2.13% 29,887
2026-09-18 1,397.90 1,442.00 1,397.90 1,431.10 +3.18% 111,449
2026-09-17 1,368.00 1,398.00 1,364.35 1,387.05 +1.14% 3,185
2026-09-16 1,340.55 1,390.05 1,317.00 1,371.45 +1.69% 14,112
2026-09-15 1,385.15 1,396.15 1,345.00 1,348.65 -2.64% 3,695
2026-09-11 1,394.40 1,395.00 1,375.85 1,385.15 -0.48% 6,196
2026-09-10 1,404.50 1,413.00 1,380.40 1,391.85 -0.55% 1,561
2026-09-09 1,368.05 1,435.75 1,368.05 1,399.50 +1.89% 8,778
2026-09-08 1,384.15 1,398.75 1,366.50 1,373.50 -0.96% 1,777
2026-09-07 1,359.55 1,416.00 1,359.55 1,386.75 +1.45% 8,100
2026-09-04 1,418.00 1,418.95 1,363.50 1,366.90 -3.64% 7,413
2026-09-03 1,418.00 1,435.50 1,406.10 1,418.55 +0.01% 8,087
2026-09-02 1,443.55 1,467.45 1,401.50 1,418.40 -1.74% 11,137
2026-09-01 1,410.00 1,468.50 1,409.95 1,443.55 +2.81% 19,929
2026-08-31 1,251.00 1,495.30 1,251.00 1,404.05 +3.91% 64,409
2026-08-28 1,353.00 1,389.70 1,337.60 1,351.25 -0.48% 4,154
2026-08-27 1,360.60 1,395.60 1,355.05 1,357.70 -0.32% 3,514
2026-08-26 1,351.70 1,369.50 1,351.70 1,362.10 +1.15% 1,719
2026-08-25 1,365.00 1,366.35 1,337.00 1,346.55 -1.37% 2,272
2026-08-24 1,348.60 1,369.25 1,337.75 1,365.30 +1.24% 4,258
2026-08-21 1,368.00 1,376.25 1,333.10 1,348.60 -1.58% 11,532
2026-08-20 1,365.45 1,401.40 1,364.80 1,370.20 +0.10% 3,136
2026-08-19 1,385.00 1,415.00 1,362.00 1,368.85 -2.15% 5,426
2026-08-18 1,405.85 1,413.75 1,373.45 1,398.90 +0.39% 4,158
2026-08-17 1,411.20 1,411.20 1,371.75 1,393.40 +0.66% 4,382
2026-08-14 1,378.75 1,391.15 1,363.65 1,384.30 +0.78% 4,106
2026-08-13 1,361.90 1,381.35 1,358.05 1,373.55 +0.86% 5,585
2026-08-12 1,385.70 1,400.60 1,350.00 1,361.90 -2.11% 7,686
2026-08-11 1,384.40 1,415.90 1,375.00 1,391.30 +1.28% 12,343
2026-08-10 1,353.50 1,385.45 1,343.10 1,373.75 +3.42% 23,766
2026-08-07 1,329.00 1,343.20 1,308.20 1,328.30 +0.52% 4,772
2026-08-06 1,332.00 1,376.00 1,315.00 1,321.40 -0.71% 12,891
2026-08-05 1,333.85 1,339.00 1,304.00 1,330.80 -0.45% 20,305
2026-08-04 1,229.95 1,356.20 1,205.25 1,336.80 +10.32% 60,407
2026-08-03 1,174.40 1,223.60 1,174.40 1,211.80 +4.54% 18,484
2026-07-31 1,111.05 1,180.50 1,111.05 1,159.20 +5.82% 24,680
2026-07-30 1,108.65 1,140.40 1,090.10 1,095.45 -2.17% 6,501
2026-07-29 1,105.15 1,129.80 1,105.15 1,119.70 +1.39% 1,547
2026-07-28 1,138.20 1,138.20 1,099.00 1,104.35 -2.31% 1,387
2026-07-27 1,101.80 1,163.00 1,101.80 1,130.50 +2.63% 7,875
2026-07-24 1,118.95 1,118.95 1,087.50 1,101.55 -0.23% 6,028
2026-07-23 1,123.40 1,134.40 1,100.20 1,104.05 -2.91% 2,601
2026-07-22 1,131.05 1,146.85 1,130.80 1,137.15 -0.72% 3,509
2026-07-21 1,096.65 1,156.75 1,096.65 1,145.40 +1.03% 6,669
2026-07-20 1,126.35 1,144.70 1,123.80 1,133.70 -0.03% 45,568
2026-07-17 1,158.30 1,169.95 1,111.80 1,134.00 -2.59% 10,293
2026-07-16 1,177.95 1,190.00 1,151.00 1,164.10 -0.31% 25,567
2026-07-15 1,175.00 1,179.70 1,161.60 1,167.70 +0.58% 2,243
2026-07-14 1,165.00 1,173.65 1,152.00 1,161.00 +0.34% 5,558
2026-07-13 1,160.15 1,175.00 1,144.85 1,157.05 -0.29% 9,690
2026-07-10 1,152.70 1,164.00 1,150.50 1,160.45 +1.58% 2,144
2026-07-09 1,143.80 1,170.00 1,139.00 1,142.45 +1.38% 34,006
2026-07-08 1,140.45 1,184.45 1,115.20 1,126.90 -1.65% 21,487
2026-07-07 1,165.95 1,168.70 1,134.75 1,145.85 -0.35% 1,557
2026-07-06 1,152.30 1,158.45 1,140.70 1,149.85 -0.61% 1,711
2026-07-03 1,155.80 1,185.00 1,148.30 1,156.95 -0.22% 10,782
2026-07-02 1,142.75 1,193.30 1,142.75 1,159.50 +2.23% 10,320
2026-07-01 1,171.15 1,181.80 1,107.55 1,134.25 -1.89% 9,516
2026-06-30 1,134.75 1,176.00 1,121.80 1,156.05 +3.18% 24,984
2026-06-29 1,118.40 1,137.00 1,108.30 1,120.45 +1.24% 5,804
2026-06-25 1,132.15 1,132.15 1,103.25 1,106.75 -0.84% 8,472
2026-06-24 1,124.95 1,134.45 1,110.05 1,116.10 -0.17% 55,027
2026-06-23 1,090.00 1,130.00 1,090.00 1,118.05 +3.28% 42,066
2026-06-22 1,078.50 1,086.00 1,069.25 1,082.50 +1.27% 2,417
2026-06-19 1,069.50 1,085.00 1,058.35 1,068.90 +0.86% 6,919
2026-06-18 1,047.10 1,063.95 1,047.10 1,059.80 +0.96% 3,078
2026-06-17 1,039.45 1,059.00 1,039.45 1,049.70 +0.73% 2,532
2026-06-16 1,067.15 1,067.15 1,036.05 1,042.05 -0.90% 9,070
2026-06-15 1,052.00 1,069.25 1,046.90 1,051.55 +0.44% 11,050
2026-06-12 1,025.00 1,079.15 1,024.95 1,046.95 +2.45% 20,799
2026-06-11 1,025.00 1,046.60 1,008.65 1,021.95 -0.79% 6,675
2026-06-10 1,041.95 1,052.00 1,022.90 1,030.05 -0.44% 36,596
2026-06-09 1,010.80 1,037.65 1,008.40 1,034.65 +3.40% 3,717
2026-06-08 1,029.80 1,045.45 996.05 1,000.60 -2.94% 54,732
2026-06-05 1,036.20 1,046.05 1,026.50 1,030.95 -0.48% 52,944
2026-06-04 1,034.95 1,056.55 1,032.00 1,035.95 -0.03% 53,330
2026-06-03 1,059.30 1,059.30 1,030.00 1,036.25 -1.10% 69,885
2026-06-02 1,038.45 1,062.60 1,030.55 1,047.80 -0.06% 32,259
2026-06-01 1,056.55 1,089.15 1,038.55 1,048.40 -0.77% 55,148
2026-05-29 1,098.25 1,098.60 1,049.40 1,056.55 -1.29% 4,925
2026-05-27 1,110.20 1,110.20 1,066.15 1,070.40 -1.66% 1,569
2026-05-26 1,065.40 1,123.00 1,065.40 1,088.50 +3.86% 5,348
2026-05-25 1,045.05 1,064.20 1,033.00 1,048.00 +1.16% 64,684
2026-05-22 1,056.70 1,064.85 1,031.55 1,035.95 -1.87% 103,818
2026-05-21 1,079.95 1,079.95 1,049.60 1,055.65 -0.35% 32,622
2026-05-20 1,068.00 1,078.20 1,054.20 1,059.40 -0.15% 21,819
2026-05-19 1,050.45 1,073.05 1,050.00 1,060.95 +0.49% 3,111
2026-05-18 1,030.05 1,060.55 1,021.05 1,055.75 +1.04% 6,824

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 14 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: Alivus Life Sciences Limited, ISIN INE03Q201024.

Promoters and group
74.85%
-0.02 pp vs Jun 2026
Foreign portfolio investors
5.93%
+0.39 pp vs Jun 2026
Domestic institutions
7.03%
-0.15 pp vs Jun 2026
Mutual funds
5.29%
-0.36 pp vs Jun 2026
Public (all, Category B)
25.15%
+0.02 pp vs Jun 2026
Resident individuals up to Rs 2 lakh
9.00%
-0.30 pp vs Jun 2026

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group74.87%74.85%-0.02 pp0-0.06 ppNo material change.
Foreign portfolio investors5.54%5.93%+0.39 pp+482,848-Reported foreign portfolio holding rose. Check the share count and the company results before drawing a conclusion.
Domestic institutions7.18%7.03%-0.15 pp-183,426-Reported domestic institutional holding fell. Mutual funds and insurers are already inside this total.
Mutual funds5.65%5.29%-0.36 pp-445,965-Reported mutual fund holding fell. Mutual funds are part of domestic institutions, not an addition to it.
Public (all, Category B)25.13%25.15%+0.02 pp-+0.06 ppNo material change.
Resident individuals up to Rs 2 lakh9.30%9.00%-0.30 pp-366,917-Reported small resident holders fell. A percentage change is not proof that retail investors bought or sold.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Sep 2026 filing.

NameTypeShares% of companyLocked-in shares
Nirma LimitedBodies Corporate9,18,96,28574.85% -
Quant Mutual Fund - Quant Small Cap FundMutual Funds Or UTI35,04,2962.85% -
Government Pension Fund GlobalInstitutions Foreign Portfolio Investor One28,65,0002.33% -
Massachusetts Institute of TechnologyInstitutions Foreign Portfolio Investor One15,04,0001.23% -
Old Bridge Focused FundMutual Funds Or UTI13,19,5121.07% -
HUF (name not given)HUF2,97,6170.24% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202674.85%-0.02 pp25.15%+0.02 pp14 Oct 2026
Jun 202674.87%0.00 pp25.13%0.00 pp13 Jul 2026
Mar 202674.87%-0.04 pp25.13%+0.04 pp14 Apr 2026
Dec 202574.91%0.00 pp25.09%0.00 pp19 Jan 2026
Sep 202574.91%-0.03 pp25.09%+0.03 pp10 Oct 2025
Jun 202574.94%-0.05 pp25.06%+0.05 pp21 Jul 2025
Mar 202574.99%-0.01 pp25.01%+0.01 pp14 Apr 2025NSE
Dec 202475.00%0.00 pp25.00%0.00 pp16 Jan 2025NSE
Sep 2024 revised75.00%-7.85 pp25.00%+7.85 pp14 Oct 2024NSE
Jun 2024 revised82.85%0.00 pp17.15%0.00 pp16 Jul 2024NSE
Mar 202482.85%0.00 pp17.15%0.00 pp19 Apr 2024NSE
Dec 202382.85%0.00 pp17.15%0.00 pp12 Jan 2024NSE
Sep 202382.85%0.00 pp17.15%0.00 pp18 Oct 2023NSE
Jun 202382.85%0.00 pp17.15%0.00 pp19 Jul 2023NSE
Mar 202382.85%0.00 pp17.15%0.00 pp13 Apr 2023NSE
Dec 202282.85%0.00 pp17.15%0.00 pp13 Jan 2023NSE
Sep 202282.85%0.00 pp17.15%0.00 pp21 Oct 2022NSE
Jun 202282.85%0.00 pp17.15%0.00 pp19 Jul 2022NSE
Mar 202282.85%0.00 pp17.15%0.00 pp19 Apr 2022NSE
Dec 2021 revised82.85%+0.01 pp17.15%-0.01 pp20 Jan 2022NSE
Sep 202182.84%0.00 pp17.16%0.00 pp20 Oct 2021NSE
Aug 202182.84%-17.16%-08 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.